Hadir Karam | Antimicrobial | Innovative Research Award

Posted on by International Research Awards on Infectious Diseases

Innovative Research Award

Hadir Karam – Misr University for Science and Technology – Egypt

Hadir Karam
Affiliation Misr University for Science and Technology
Country Egypt
Google Scholar ID yfAiXzAAAAAJ
Documents 1
Citations 5
h-index 1
Subject Area Antimicrobial
Event International Research Awards on Infectious Diseases
ORCID 0000-0003-4753-7529

The Innovative Research Award recognizes research contributions that demonstrate originality, scientific relevance, and potential value to their respective fields. This article presents a structured overview of Hadir Karam’s supplied academic profile, institutional affiliation, reported research metrics, and potential relevance to antimicrobial research within the broader field of infectious diseases. The information is organized for academic reference and should be interpreted in accordance with the limitations of the available profile data.

Abstract

Hadir Karam is identified in the supplied profile information as being affiliated with Misr University for Science and Technology in Egypt, with antimicrobial research listed as the principal subject area. The profile data provided for this article report one document, five citations, and an h-index of one. These indicators offer a limited quantitative snapshot of the research record but do not independently establish the originality, methodological quality, or practical significance of an individual contribution. This article outlines the relevance of antimicrobial research to infectious disease research and describes considerations for evaluating potential suitability for an Innovative Research Award. The information should be verified against the researcher’s current bibliographic records and the award organizer’s official criteria before being used for formal recognition. [1] [2]

Keywords

Hadir Karam, Innovative Research Award, antimicrobial research, infectious diseases, antimicrobial agents, scientific innovation, research evaluation, bibliometrics, scholarly publications, Egypt, Misr University for Science and Technology.

Introduction

Antimicrobial research is an important component of biomedical science because it addresses the prevention, detection, and treatment of infections caused by bacteria, fungi, viruses, and other microorganisms. Research in this area can involve the investigation of antimicrobial compounds, mechanisms of resistance, therapeutic effectiveness, pathogen biology, and strategies for improving the responsible use of antimicrobial agents. Antimicrobial resistance is recognized internationally as a significant public health challenge requiring coordinated research, surveillance, and intervention. [3]

Research Profile

The supplied profile identifies Hadir Karam as a researcher affiliated with Misr University for Science and Technology, Egypt. Antimicrobial research is the stated subject area. An ORCID identifier has also been provided, enabling access to a persistent researcher identifier that can assist with distinguishing scholarly records and connecting research outputs with their author. [2]

Research Contributions

Antimicrobial research encompasses a range of scientific questions relevant to infectious disease management. Potential contributions in this subject area may include the identification of candidate antimicrobial compounds, characterization of microbial susceptibility, investigation of resistance mechanisms, evaluation of treatment approaches, and development of improved laboratory methods. The significance of any particular contribution depends on the research question, supporting evidence, and relevance to the field..[3]

Publications

The supplied bibliometric information lists one document associated with the researcher. However, a publication title, author list, journal name, publication year, and DOI were not included in the source information provided for this article. It is therefore not possible to produce a verified publication bibliography or to assign a particular scientific finding to the reported document without further records.[3]

Research Impact

Research impact can be examined through complementary quantitative and qualitative indicators. Quantitative indicators summarize publication and citation patterns, whereas qualitative assessment considers the scientific content, reliability, originality, and potential significance of the work. Neither type of evidence should be treated as a complete measure of research quality in isolation. [2]

Award Suitability

The Innovative Research Award is associated in the supplied information with the International Research Awards on Infectious Diseases. Given the stated subject area of antimicrobial research, the researcher’s profile may be relevant to an award program concerned with infectious disease research. Final eligibility and suitability, however, depend on the organizer’s published criteria and an assessment of the actual research submission.[1]

Conclusion

Hadir Karam is identified in the supplied information as being affiliated with Misr University for Science and Technology in Egypt, with antimicrobial research listed as the subject area. The profile metrics provided for this article comprise one document, five citations, and an h-index of one. These figures offer a limited bibliometric overview and should be interpreted alongside the underlying research outputs.[2]

References

  1. Google Scholar. (n.d.). Google Scholar profile of Hadir Karam. Google Scholar.
    https://scholar.google.com/citations?user=yfAiXzAAAAAJ&hl=en
  2. Ahmed, H. K., Molham, F., El-Gendy, A. O., & Ahmed, M. A. E.-S. (n.d.). Coexistence of carbapenem resistance and hypervirulence in clinical Klebsiella pneumoniae isolates: A molecular and phenotypic analysis.
    https://link.springer.com/article/10.1186/s12879-025-11585-z
  3. ORCID. (n.d.). ORCID profile of Hadir Karam. ORCID Registry.
    https://orcid.org/0000-0003-4753-7529

Aasia Kalsoom | Development of New Vaccines | Innovative Research Award

Posted on by International Research Awards on Infectious Diseases

Innovative Research Award

Aasia Kalsoom – Pakistan Council of Scientific and Industrial Research – Pakistan

Aasia Kalsoom
Affiliation Pakistan Council of Scientific and Industrial Research
Country Pakistan
Scopus ID 57204200924
Documents 8
Citations 56
h-index 4
Subject Area Development of New Vaccines
Event International Research Awards on Infectious Diseases

The Innovative Research Award is a research recognition category associated with the International Research Awards on Infectious Diseases. This article presents the supplied bibliographic profile of Aasia Kalsoom, affiliated with the Pakistan Council of Scientific and Industrial Research in Pakistan, with a stated subject area of development of new vaccines. The profile includes publication and citation indicators attributed to the researcher’s supplied Scopus author record. These metrics provide a quantitative overview of indexed scholarly output but do not, on their own, establish the novelty, quality, or clinical impact of individual research contributions. [1]

Abstract

This article outlines the available research-profile information for Aasia Kalsoom, whose stated institutional affiliation is the Pakistan Council of Scientific and Industrial Research. The supplied Scopus profile identifies eight documents, 56 citations, and an h-index of 4. The stated subject area is the development of new vaccines, a field relevant to infectious disease prevention, immunology, antigen research, and vaccine development. The article discusses the significance and limitations of these indicators in the context of research recognition. Specific publications, experimental findings, author contributions, and independently verified award decisions have not been supplied and are therefore not asserted here. [1] [2]

Keywords

Aasia Kalsoom; Innovative Research Award; Pakistan Council of Scientific and Industrial Research; Pakistan; development of new vaccines; infectious diseases; vaccine research; scientific publications; citation analysis; research impact; Scopus author profile; biomedical research.

Introduction

Vaccine development is an important component of infectious disease research. It involves the identification of protective antigens, evaluation of immune responses, assessment of safety, and investigation of strategies that can prevent or reduce the burden of infectious diseases. Research in this area can involve microbiology, immunology, molecular biology, biotechnology, clinical investigation, and public health. The translation of laboratory findings into effective vaccines requires evidence from appropriate experimental and clinical studies. [2] [3]

Research Profile

Aasia Kalsoom is associated in the supplied information with the Pakistan Council of Scientific and Industrial Research in Pakistan. The stated subject area is development of new vaccines. The Scopus author identifier provided for this profile is 57204200924. The profile can be consulted through the publisher’s author-detail page to examine indexed records and associated bibliographic information. [1]

Research Contributions

The supplied subject area places the research profile within the broad field of new vaccine development. Vaccine research can address scientific questions about pathogen biology, antigen selection, immune recognition, immunogenicity, protective efficacy, safety, and implementation. The specific contribution of an individual researcher must, however, be established from publications, project records, documented author roles, and relevant experimental or clinical evidence. [2] [3]

Publications

The supplied bibliometric information lists eight documents associated with the Scopus author identifier 57204200924. A publication-by-publication inventory has not been provided for this article. The linked Scopus author page is the appropriate starting point for verifying document titles, author lists, source titles, publication dates, citation records, and available digital object identifiers. [1]

Research Impact

The supplied profile reports 56 citations across eight documents and an h-index of 4. These indicators describe aspects of the recorded scholarly attention associated with the profile. Citation counts can help identify research outputs that have been referenced by later publications, while the h-index combines publication productivity and citation frequency into a single measure. Neither measure directly evaluates methodological quality, originality, clinical usefulness, or the accuracy of research findings. [1] [3]

Award Suitability

The Innovative Research Award is associated here with the International Research Awards on Infectious Diseases. The supplied institutional affiliation, stated vaccine-development subject area, and bibliometric profile provide contextual information that may be relevant when considering research in the infectious diseases field. The available data alone do not establish eligibility, nomination status, selection, or receipt of the award.[1]

Conclusion

Aasia Kalsoom’s supplied research profile identifies an affiliation with the Pakistan Council of Scientific and Industrial Research in Pakistan and a subject area of development of new vaccines. The provided Scopus indicators comprise eight documents, 56 citations, and an h-index of 4. These figures offer a limited quantitative description of indexed research activity. A fuller scholarly assessment would require verification of the author record, examination of individual publications, and evidence of specific contributions to vaccine or infectious diseases research. Award eligibility and recognition should be established through the official program and its documented evaluation process.[3]

References

  1. Elsevier. (n.d.). Scopus author details: Aasia Kalsoom, Author ID 57204200924. Scopus. Author-profile metrics and document records should be checked against the current database entry.
    https://www.scopus.com/authid/detail.uri?authorId=57204200924
  2. Rasool, M., Malik, A., Waquar, S., Tul-Ain, Q., Jafar, T. H., Rasool, R., & Kalsoom, A. (n.d.). In-silico characterization and in-vivo validation of Albiziasaponin-A, iso-orientin, and salvadorin using a rat model of Alzheimer’s disease.
    https://pubmed.ncbi.nlm.nih.gov/30123124/
  3. Kalsoom, A., Abidi, S. H., Marwat, S. A., Shabbir, G., Naveed, M., & Mughal, A. M. A. (n.d.). Immunopharmacological and structural design of a polyprotein-based multi-epitope vaccine against Powassan virus.
    https://link.springer.com/article/10.1007/s00210-026-05519-y

Esra Cakmak Tashkin | Pediatric Infectious Diseases | Innovative Research Award

Posted on by International Research Awards on Infectious Diseases

Innovative Research Award

Esra Cakmak Tashkin · Kocaeli City Hospital · Turkey

Esra Cakmak Tashkin
Affiliation Kocaeli City Hospital
Country Turkey
Scopus ID 57208641409
Documents 13
Citations 24
h-index 2
Subject Area Pediatric Infectious Diseases
Event International Research Awards on Infectious Diseases
ORCID 0000-0002-3574-0370

Esra Cakmak Tashkin is a researcher affiliated with Kocaeli City Hospital in Turkey, whose supplied academic profile identifies pediatric infectious diseases as the relevant subject area. The researcher profile lists 13 documents, 24 citations, and an h-index of 2. These bibliometric indicators provide a quantitative overview of the research record reported in the supplied information; they do not independently establish the quality or clinical significance of individual publications. [1]

Abstract

This article provides a structured overview of Esra Cakmak Tashkin’s reported research profile and its relevance to pediatric infectious diseases. The supplied profile identifies Kocaeli City Hospital in Turkey as the institutional affiliation and reports 13 documents, 24 citations, and an h-index of 2 in Scopus. The research area is relevant to the study, prevention, diagnosis, and management of infectious diseases in children. The article also outlines general criteria for considering research contributions for an Innovative Research Award. Because individual publication records, abstracts, and full-text articles have not been independently examined here, specific scientific findings and award outcomes are not attributed to the researcher without supporting evidence. [1]

Keywords

Esra Cakmak Tashkin, pediatric infectious diseases, infectious disease research, clinical research, child health, research evaluation, bibliometrics, Scopus, ORCID, Innovative Research Award, International Research Awards on Infectious Diseases, Kocaeli City Hospital, Turkey.

Introduction

Pediatric infectious diseases is a medical specialty concerned with infections affecting infants, children, and adolescents. Its scope includes the investigation of infectious agents, disease transmission, diagnostic methods, antimicrobial treatment, vaccination, prevention strategies, and complications associated with infection. Research in this field can contribute to evidence-based clinical decisions and improved approaches to pediatric care.[1] [2]

Research Profile

The supplied profile identifies Esra Cakmak Tashkin as affiliated with Kocaeli City Hospital, Turkey, and associates the research record with pediatric infectious diseases. The Scopus author identifier is 57208641409, and the ORCID iD is 0000-0002-3574-0370. These identifiers provide direct routes for examining the respective author records and checking the most current available information. [1] [2]

Research Contributions

Pediatric infectious diseases research encompasses a broad range of clinical and scientific questions. Depending on the specific research design and subject investigated, relevant contributions may include improved recognition of infections, assessment of diagnostic performance, evaluation of treatment outcomes, investigation of antimicrobial resistance, and the development of evidence-based prevention approaches. These are general areas of the specialty and should not be interpreted as verified descriptions of this researcher’s individual studies.[3]

Publications

The supplied Scopus profile information reports 13 documents associated with the researcher. The number provides a broad indication of the size of the indexed publication record, but it does not identify individual articles, their titles, publication dates, co-authors, journals, or digital object identifiers (DOIs). Those details should be obtained from the current author record and the corresponding publisher pages before being presented as verified publication information. [1]

Research Impact

Research impact can be considered through several complementary forms of evidence, including scholarly citations, the use of research findings in subsequent studies, methodological influence, clinical relevance, collaboration, and contributions to public health. The appropriate indicators depend on the research question, discipline, publication history, and intended audience.[3]

Award Suitability

The Innovative Research Award, associated here with the International Research Awards on Infectious Diseases, is relevant in scope to researchers whose work contributes to infectious disease science. For a candidate working in pediatric infectious diseases, an appropriate assessment would examine the originality, scientific rigor, clinical significance, and potential contribution of the nominated research to the understanding or management of infections in children.[1]

Conclusion

Esra Cakmak Tashkin is identified in the supplied profile as a researcher affiliated with Kocaeli City Hospital in Turkey, with pediatric infectious diseases listed as the subject area. The reported Scopus indicators comprise 13 documents, 24 citations, and an h-index of 2. The Scopus and ORCID links provide starting points for examining the research record and verifying current bibliographic information.[2]

References

  1. Elsevier. (n.d.). Scopus author details: Esra Cakmak Tashkin, Author ID 57208641409. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57208641409
  2. ORCID. (n.d.). ORCID record: 0000-0002-3574-0370.
    https://orcid.org/0000-0002-3574-0370
  3. Taskin, E. C., Arga, G., Arslan, B. C., Taskin Karacay, I. E., Genceli, M., Erdeniz, E. H., Kaba, O., Avcu, G., Kus, S., Abaci Capar, M. C., et al. (n.d.). Pediatric invasive meningococcal disease in Türkiye during the post-pandemic period: Increased reported cases and predominance of serogroup B and severity determined by a clinical form in a multicenter hospital-based cohort.
    https://link.springer.com/article/10.1007/s00431-026-07399-z

Haoxue Zhu | Hepatitis | Innovative Research Award

Posted on by International Research Awards on Infectious Diseases

Innovative Research Award

Haoxue Zhu
Peking Union Medical College Hospital, China

Haoxue Zhu
Affiliation Peking Union Medical College Hospital
Country China
Scopus ID 57567489400
Documents 7
Citations 63
h-index 3
Subject Area Hepatitis
Event International Research Awards on Infectious Diseases

Haoxue Zhu is a researcher affiliated with Peking Union Medical College Hospital in China whose indexed scholarly work is associated with the field of hepatitis and infectious diseases. The available bibliometric profile records 7 documents, 63 citations, and an h-index of 3 in Scopus. These indicators provide a quantitative overview of the researcher’s indexed scholarly output and citation activity. [1]

Abstract

This academic profile presents the research record of Haoxue Zhu, affiliated with Peking Union Medical College Hospital, China, within the subject area of hepatitis. The available Scopus information identifies 7 indexed documents, 63 citations, and an h-index of 3. [1] The profile is relevant to infectious-disease scholarship because hepatitis research addresses major questions concerning viral infection, disease burden, diagnosis, treatment, prevention, and long-term clinical outcomes. [2]

Keywords

Hepatitis, Infectious diseases, Clinical research, Viral infections, Hepatology, Medical research, Research impact

Introduction

Hepatitis encompasses inflammatory disorders of the liver arising from diverse infectious and non-infectious causes. Viral hepatitis remains a significant area of global health research, with hepatitis B and hepatitis C among the principal viral causes of chronic liver disease, cirrhosis, and hepatocellular carcinoma. Research in this field therefore intersects infectious disease, internal medicine, hepatology, epidemiology, diagnostics, and public health. [2]

Research Profile

The available bibliometric information identifies Haoxue Zhu with Scopus Author ID 57567489400. The profile contains 7 indexed documents and records 63 citations, with an h-index of 3. [1] These metrics indicate an established, though relatively focused, body of indexed scholarly output.

Research Contributions

Based on the supplied subject classification, the research portfolio is centered on hepatitis. This field encompasses several interconnected areas of scientific and clinical investigation, including the characterization of viral infection, disease diagnosis, therapeutic intervention, monitoring of chronic infection, and prevention of transmission. [1]

Publications

The supplied bibliometric record indicates 7 indexed documents associated with Scopus Author ID 57567489400. [1] Because complete article-level bibliographic information was not supplied, this profile does not attribute specific titles, journals, publication years, or DOI identifiers to individual works without independent verification. [1]

Research Impact

Research impact can be considered through several complementary dimensions, including scholarly output, citation activity, scientific relevance, clinical applicability, and contribution to a research field. For Haoxue Zhu, the available Scopus indicators comprise 7 documents, 63 citations, and an h-index of 3.[1]

Award Suitability

The Innovative Research Award is considered suitable for a profile demonstrating research activity within a relevant scientific field and evidence of scholarly dissemination. Haoxue Zhu’s documented association with hepatitis research, together with the recorded Scopus publication and citation indicators, provides a factual basis for consideration within an infectious-disease research recognition framework. [1][2]

Conclusion

Haoxue Zhu, affiliated with Peking Union Medical College Hospital in China, has a documented research profile centered on hepatitis. The supplied Scopus information records 7 documents, 63 citations, and an h-index of 3. [1] These indicators demonstrate measurable scholarly activity within a field that has substantial relevance to infectious-disease research and public health. [2]

References

  1. Elsevier. (n.d.). Scopus author details: Haoxue Zhu, Author ID 57567489400. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57567489400
  2. Yi, X., Zhu, H., He, M., Gao, S.M., & Li, M.M. Decoding Links between Gut Microbiota and Metabolic-associated Fatty Liver Disease: Meta-analysis and Mediation Study Uncover Species-specific Taxa and a Novel Bile Acid Mediator.
    https://www.sciencedirect.com/science/article/pii/S0895398826000383

Jiann-Ruey Hong | Functional additives DHA | Innovative Research Award

Posted on by International Research Awards on Infectious Diseases

Innovative Research Award

Jiann-Ruey Hong
National Cheng Kung University, Taiwan

Jiann-Ruey Hong
Affiliation National Cheng Kung University
Country Taiwan
Scopus ID 7404117952
Documents 64
Citations 2,117
h-index 29
Subject Area Functional additives DHA
Event International Research Awards on Infectious Diseases
ORCID 0000-0003-3886-5192

Jiann-Ruey Hong is affiliated with National Cheng Kung University in Taiwan. The researcher profile associated with Scopus Author ID 7404117952 records 64 documents, 2,117 citations, and an h-index of 29. These bibliometric indicators provide a structured description of the indexed research record and are presented here as profile information rather than as an independent assessment of research quality. [1]

Abstract

This academic recognition profile presents the documented research information associated with Jiann-Ruey Hong of National Cheng Kung University, Taiwan. The profile includes bibliometric indicators attributed to the Scopus author record, together with the research subject area identified as functional additives DHA. The available profile records 64 documents, 2,117 citations, and an h-index of 29. [1] ORCID provides an additional persistent researcher identifier for distinguishing the scholarly record associated with the researcher. [2]

Keywords

Jiann-Ruey Hong, National Cheng Kung University, Functional additives, DHA, Research innovation, Bibliometrics, Infectious diseases research, Research awards

Introduction

Academic recognition profiles commonly bring together institutional affiliation, persistent researcher identifiers, publication records, and citation-based indicators to provide a concise view of scholarly activity. Scopus is an abstract and citation database that maintains author profiles and associated bibliometric information, while ORCID provides a persistent digital identifier intended to distinguish researchers and connect their scholarly contributions. [1] [2]

Research Profile

The supplied researcher information identifies Jiann-Ruey Hong with National Cheng Kung University in Taiwan. The corresponding Scopus Author ID is 7404117952. The indexed profile contains 64 documents, 2,117 citations, and an h-index of 29. [1]

Research Contributions

The supplied profile identifies functional additives DHA as the subject area associated with the researcher information. This subject description provides a thematic context for interpreting the research profile but does not, by itself, establish the specific findings, methods, applications, or individual contributions contained within each publication. [1] [2]

Publications

The Scopus author record supplied for this profile contains 64 indexed documents. [1] These documents form the publication base from which the reported citation and h-index indicators are derived. Individual publication titles, journals, publication years, co-authors, and DOI identifiers are not reproduced here unless independently specified in the supplied information.[1] [2]

Research Impact

The supplied Scopus profile reports 2,117 citations and an h-index of 29. [1] These are quantitative bibliometric indicators of the indexed record. Citation counts can reflect differences in field practices, publication age, database coverage, collaboration patterns, and other factors; therefore, they should be interpreted alongside publication content and other evidence when evaluating scholarly work. [4]

Award Suitability

The profile is presented in connection with the Innovative Research Award under the International Research Awards on Infectious Diseases. The supplied research subject area, functional additives DHA, together with the documented publication and citation profile, provides information that may be considered as part of an academic recognition profile. [3]

Conclusion

Jiann-Ruey Hong is identified in the supplied profile as a researcher affiliated with National Cheng Kung University, Taiwan, with Scopus Author ID 7404117952. The associated record reports 64 documents, 2,117 citations, and an h-index of 29, with functional additives DHA identified as the subject area. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Jiann-Ruey Hong, Author ID 7404117952. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7404117952
  2. ORCID. (n.d.). ORCID record: Jiann-Ruey Hong. ORCID.
    https://orcid.org/0000-0003-3886-5192
  3. Hong, J. R., Lin, T. L., Hsu, Y. L., & Wu, J. L. (1998). Apoptosis precedes necrosis of fish cell line with infectious pancreatic necrosis virus infection.
    https://www.sciencedirect.com/science/article/pii/S0042682298993473
  4. Reshi, L., Wu, J. L., Wang, H. V., & Hong, J. R. (2016). Aquatic viruses induce host cell death pathways and their application.
    https://www.sciencedirect.com/science/article/abs/pii/S0168170215300988

Prince Mushunje | Pediatric Infectious Diseases | Innovative Research Award

Posted on by International Research Awards on Infectious Diseases

Innovative Research Award

Prince Mushunje
Molecular and Cell Biology Building
South Africa

Prince Mushunje
Affiliation Molecular and Cell Biology Building
Country South Africa
Scopus ID 58644772200
Documents 2
Citations 5
h-index 1
Subject Area Pediatric Infectious Diseases
Event International Research Awards on Infectious Diseases
ORCID 0000-0003-2813-6068

Prince Mushunje is a researcher associated with the Molecular and Cell Biology Building in South Africa, with a stated subject-area focus on Pediatric Infectious Diseases. The available bibliographic information records two documents, five citations, and an h-index of 1. These indicators provide a concise quantitative description of the researcher’s indexed scholarly output and citation activity. [1]

Abstract

Prince Mushunje is associated with research in Pediatric Infectious Diseases at the Molecular and Cell Biology Building in South Africa. Available indexed information identifies two scholarly documents and five citations, with an h-index of 1, providing a limited but measurable bibliometric profile. The research focus is relevant to pediatric infectious disease science, an interdisciplinary field concerned with infection biology, disease prevention, diagnosis, treatment, and outcomes among children. This academic recognition profile presents the available research information in a structured manner and considers the relationship between documented scholarly activity and the Innovative Research Award. The assessment remains evidence-based and avoids claims beyond the supplied bibliographic information.[1]

Keywords

Pediatric Infectious Diseases, infectious disease research, pediatric health, molecular and cell biology, infection research, clinical research, scholarly publications, research impact, bibliometrics, Innovative Research Award.[2]

Introduction

Pediatric infectious diseases encompass research addressing infectious conditions affecting infants, children, and adolescents, including mechanisms of infection, host responses, epidemiology, diagnostics, prevention, and therapeutic strategies. The field frequently integrates molecular biology with clinical and population-level approaches. Prince Mushunje’s stated subject area places the research profile within this broad scientific domain. [2]

Research Profile

The available profile identifies Prince Mushunje with the Molecular and Cell Biology Building in South Africa and associates the researcher with Pediatric Infectious Diseases. The Scopus author identifier is 58644772200. Indexed records supplied for this article indicate two documents, five citations, and an h-index of 1. [1]

Research Contributions

Research in Pediatric Infectious Diseases can contribute to understanding infection mechanisms, improving diagnostic approaches, supporting prevention strategies, and informing clinical management of childhood infections. Within the information supplied for this profile, Prince Mushunje’s contribution is represented through indexed scholarly documents associated with the stated subject area.[3]

Publications

Prince Mushunje has contributed two indexed scholarly publications within the field of Pediatric Infectious Diseases. These publications have collectively received five citations, demonstrating engagement with the broader scientific literature. His documented research activity reflects an interest in infectious disease research involving pediatric health and molecular and cellular perspectives, contributing to ongoing scientific knowledge. [1]

Research Impact

The available bibliometric indicators show five citations across two indexed documents and an h-index of 1. Citation counts and h-index values are quantitative measures that can help describe scholarly visibility, although they should be interpreted alongside publication quality, research significance, collaboration, field norms, and the age of the publications. The available data therefore demonstrate measurable citation activity while remaining insufficient for broader conclusions about long-term research influence. [1]

Award Suitability

The Innovative Research Award recognizes research activity that demonstrates relevance, originality, and scholarly contribution within its designated field. Prince Mushunje’s documented research area in Pediatric Infectious Diseases is aligned with infectious disease research. The available record of two documents and five citations provides evidence of scholarly activity, while assessment of innovation should additionally consider the underlying research methods, findings, originality, and supporting documentation submitted for evaluation.[2]

Conclusion

Prince Mushunje’s academic profile is associated with Pediatric Infectious Diseases and the Molecular and Cell Biology Building in South Africa. The supplied Scopus information records two documents, five citations, and an h-index of 1. These indicators establish a documented scholarly profile, while a complete assessment of research innovation requires consideration of the underlying publications, scientific findings, originality, and evidence submitted for award review. [1]

References

  1. Elsevier. (n.d.). Scopus author details: Prince Mushunje, Author ID 58644772200. Scopus.
    https://www.scopus.com/pages/authors/58644772200
  2. ORCID. (n.d.). ORCID profile of Prince Mushunje. ORCID Registry.
    https://orcid.org/0000-0003-2813-6068
  3. Mushunje, P. K., Dube, F. S., Olwagen, C., Madhi, S., Odland, J. Ø., Ferrand, R. A., Nicol, M. P., Abotsi, R. E., BREATHE Study Team, Bandason, T., et al. (n.d.). Characterization of bacterial and viral pathogens in the respiratory tract of children with HIV-associated chronic lung disease: A case–control study.
    https://link.springer.com/article/10.1186/s12879-024-09540-5

Louis Picker | HIV cure | Innovative Research Award

Posted on by International Research Awards on Infectious Diseases

Innovative Research Award

Louis Picker
Oregon Health & Science University
Researcher Information
Affiliation Oregon Health & Science University
Country United States
Scopus ID 7005304033
Documents 257
Citations 37,921
h-index 90
Subject Area HIV cure
Event International Research Awards on Infectious Diseases

The Innovative Research Award recognizes scholarly contributions associated with significant and sustained research activity. This article presents an academic profile of Louis Picker of Oregon Health & Science University, with particular reference to research relevant to HIV cure strategies, scientific publications, citation performance, and the suitability of his research record for recognition through the International Research Awards on Infectious Diseases.[1]

Abstract

Louis Picker is a researcher at Oregon Health & Science University whose scholarly record is associated with major investigations in immunology, virology, vaccine science, and HIV cure research. His Scopus profile reports 257 documents, 37,921 citations, and an h-index of 90, indicating substantial publication visibility and long-term citation influence. This profile evaluates his research background, contributions, publication activity, research impact, and relevance to the Innovative Research Award within the International Research Awards on Infectious Diseases, using publicly presented academic metrics and representative scientific literature.[1]

Keywords

Innovative Research Award, Louis Picker, HIV cure, HIV immunology, infectious diseases, vaccine research, persistent viral infection, Scopus, research impact, Oregon Health & Science University.[1]

Introduction

Research on HIV continues to require advances in viral persistence, host immunity, prevention, therapeutic intervention, and cure-oriented strategies. Academic recognition in this field commonly considers sustained scientific productivity, influence on subsequent research, methodological development, and relevance to unresolved infectious disease challenges. Louis Picker’s publication record provides a basis for examining these criteria within an academic recognition context.[2]

Research Profile

Louis Picker is affiliated with Oregon Health & Science University in the United States. His research profile includes work relevant to viral immunology, T-cell biology, vaccine approaches, and persistent infections. The subject area identified for this article is HIV cure, reflecting research questions concerning durable immune responses and strategies directed toward controlling or eliminating persistent infection.[1]

Research Contributions

Research associated with Picker has examined unconventional immune mechanisms and the potential of cytomegalovirus-based vaccine vectors to generate distinctive cellular immune responses. Published studies have also investigated vaccine-mediated control of simian immunodeficiency virus, providing experimental evidence relevant to broader discussions of immune-based approaches to persistent viral infection and HIV cure research.[2]

Publications

The Scopus author record associated with Scopus ID 7005304033 reports 257 documents. This publication activity spans a substantial scholarly record and provides measurable evidence of continued research dissemination. Representative publications address vaccine vectors, cellular immunity, and persistent viral infection, including studies that have contributed to scientific discussion concerning immune-mediated control of lentiviral disease.[1][2]

Research Impact

The profile reports 37,921 citations and an h-index of 90, metrics that indicate broad citation activity across the research record. Citation indicators do not independently measure scientific quality or practical impact, but they provide one quantitative perspective on how frequently published work has been referenced within subsequent scholarship. These indicators support assessment alongside research relevance and documented contributions.[1]

Award Suitability

Based on the reported publication volume, citation record, h-index, institutional affiliation, and research relevance to HIV and infectious diseases, the profile presents characteristics consistent with consideration for the Innovative Research Award. The final suitability determination would depend on the award’s formal eligibility criteria, nomination materials, supporting evidence, and comparative evaluation procedures established by the event organizers.[3]

Conclusion

Louis Picker’s academic profile reflects sustained publication activity and substantial citation visibility in areas relevant to infectious disease and HIV research. His documented work on immunological mechanisms and vaccine-based approaches provides a scholarly basis for consideration within research recognition programs. The Innovative Research Award profile should be interpreted alongside formal verification and event-specific evaluation criteria.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Louis Picker, Author ID 7005304033. Scopus.
    https://www.scopus.com/pages/authors/7005304033
  2. Grossman, Z., Meier-Schellersheim, M., Paul, W. E., & Picker, L. J. (n.d.). Pathogenesis of HIV infection: What the virus spares is as important as what it destroys.
    https://www.nature.com/articles/nm1380
  3. Goldstein, L. A., Zhou, D. F. H., Picker, L. J., Minty, C. N., Bargatze, R. F., & Ding, J. F. (n.d.). A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins.
    https://www.sciencedirect.com/science/article/abs/pii/0092867489906399

Emmanuel Andres | Cytopenia | Innovative Research Award

Posted on by International Research Awards on Infectious Diseases

Innovative Research Award

Emmanuel Andres
Strasbourg University, France

Emmanuel Andres
Affiliation Strasbourg University
Country France
Scopus ID 7103334147
Documents 701
Citations 11,426
h-index 52
Subject Area Cytopenia
Event International Research Awards on Infectious Diseases
ORCID 0000-0002-7914-7616

Emmanuel Andres is presented in this academic recognition profile as a researcher affiliated with Strasbourg University, France, with a stated research focus on cytopenia. The supplied bibliometric record lists 701 documents, 11,426 citations, and an h-index of 52. These indicators provide a quantitative description of research visibility and productivity, while interpretation should consider disciplinary practices, publication age, collaboration patterns, and database coverage. Cytopenia encompasses reductions in one or more circulating blood-cell lineages and may arise from diverse hematological, infectious, immune, nutritional, medication-related, or systemic conditions. Contemporary evaluation emphasizes structured clinical assessment, laboratory investigation, and appropriate specialist review. [1] [2]

Abstract

This academic recognition profile presents Emmanuel Andres, Strasbourg University, France, in relation to research focused on cytopenia and associated hematological investigation. The supplied scholarly indicators report 701 documents, 11,426 citations, and an h-index of 52. Cytopenia represents a clinically important finding involving reduced numbers of one or more blood-cell lineages and may reflect diverse underlying mechanisms. Research in this area intersects with hematology, infectious diseases, immunology, bone-marrow disorders, diagnostic medicine, and translational investigation. Recognition of research activity should consider documented scholarly output alongside citation impact, methodological contribution, collaboration, and relevance to evolving approaches in diagnosis and patient-centered scientific investigation. [1] [2]

Keywords

Cytopenia; pancytopenia; hematology; infectious diseases; bone marrow; thrombocytopenia; neutropenia; anemia; diagnostic medicine; clinical research; translational research; immunology.

Introduction

Cytopenia describes a reduction in the number of one or more circulating blood-cell populations. When all three major lineages are reduced, the finding is generally described as pancytopenia. Its causes are heterogeneous and can include impaired marrow production, peripheral destruction or consumption, nutritional deficiencies, medications, immune-mediated disorders, infections, malignancy, and inherited marrow-failure conditions. A systematic diagnostic approach is therefore important when interpreting abnormal blood counts. [1] [2]

Research Profile

The supplied bibliometric information identifies Emmanuel Andres with an affiliation to Strasbourg University and a stated subject area of cytopenia. The reported profile contains 701 documents, 11,426 citations, and an h-index of 52. These values indicate substantial indexed scholarly activity and citation visibility within the supplied record. Bibliometric indicators are most appropriately interpreted as descriptive measures rather than as independent measures of research quality, because citation behavior differs among disciplines and publication types. [3]

Research Contributions

Research concerning cytopenia commonly addresses the distinction between decreased cellular production and increased peripheral loss or destruction. Important investigative domains include blood-count interpretation, peripheral smear assessment, nutritional evaluation, medication review, infection-related causes, immune mechanisms, bone-marrow examination, and evaluation for hematological disease. Contemporary diagnostic algorithms emphasize a structured progression from initial blood testing toward targeted investigations based on clinical findings and the pattern of affected cell lines. [1] [2]

Publications

The supplied Scopus record reports 701 documents associated with the researcher profile. This page does not independently assign individual publications to Emmanuel Andres beyond the bibliometric information provided. The document count should therefore be understood as a supplied profile metric rather than as a manually verified publication bibliography. A complete publication assessment would require examination of the indexed records, publication types, authorship positions, subject categories, citation dates, and duplicate or merged records within the relevant database. [3]

Research Impact

The reported citation count of 11,426 and h-index of 52 provide quantitative indicators of scholarly visibility. The h-index reflects the number of publications that have each received at least the corresponding number of citations, while the total citation count reflects accumulated citations within the specified database record. Neither metric alone establishes methodological quality, clinical effectiveness, or societal impact. Such measures are best considered alongside research originality, reproducibility, collaboration, disciplinary context, and contribution to scientific knowledge. [3]

Award Suitability

Based on the supplied information, the profile presents several characteristics relevant to consideration for an innovative research recognition: a stated specialization in cytopenia, substantial documented scholarly output, a reported citation record, and an h-index of 52. These indicators may support eligibility assessment for the International Research Awards on Infectious Diseases, particularly where the award evaluation considers research productivity and relevance to infectious-disease-related scientific investigation. Final award suitability should nevertheless be determined according to the official eligibility criteria, supporting documentation, and independent review procedures of the organizing body. [4]

Conclusion

The supplied profile of Emmanuel Andres, Strasbourg University, identifies cytopenia as a principal subject area and reports 701 documents, 11,426 citations, and an h-index of 52. These metrics describe a substantial level of indexed scholarly activity and citation visibility. Cytopenia research remains multidisciplinary, connecting hematology with infectious diseases, immunology, diagnostic medicine, and translational science. A balanced assessment of research recognition should combine bibliometric evidence with publication quality, originality, scientific contribution, and relevance to the research community. [1] [2]

References

  1. Andrès, E., El Hassani Hajjam, A., Maloisel, F., Alonso-Ortiz, M. B., Méndez-Bailón, M., Lavigne, T., Jannot, X., & Lorenzo-Villalba, N. (n.d.). Artificial intelligence (AI) and drug-induced and idiosyncratic cytopenia: The role of AI in prevention, prediction, and patient participation.
    https://www.mdpi.com/2038-8330/17/3/24
  2. Kurz, C. L., Chauvet, S., Andrès, E., Aurouze, M., Vallet, I., Michel, G. P. F., & M. (n.d.). Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screening.
    https://pubmed.ncbi.nlm.nih.gov/12660152/
  3. Elsevier. (n.d.). Scopus author details: Emmanuel Andres, Author ID 7103334147. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7103334147
  4. Riou, M., Alfatni, A., Charles, A. L., Andres, E., Pistea, C., Charloux, A., & Geny, B. (n.d.). New insights into the implication of mitochondrial dysfunction in tissue, peripheral blood mononuclear cells, and platelets during lung diseases.
    https://pubmed.ncbi.nlm.nih.gov/32357474/

Giuseppe Stragliotto | Virus | Innovative Research Award

Posted on by International Research Awards on Infectious Diseases

Innovative Research Award

Giuseppe Stragliotto
Karolinska University Hospital, Stockholm

Giuseppe Stragliotto
Affiliation Karolinska University Hospital, Stockholm
Country Sweden
Scopus ID 6602379408
Documents 31
Citations 3306
h-index 18
Subject Area Virus
Event International Research Awards on Infectious Diseases
ORCID 0000-0003-1968-6447

The Innovative Research Award recognizes sustained scientific contributions that advance knowledge in virology and infectious disease research. Giuseppe Stragliotto has established an academic profile through peer-reviewed publications, collaborative investigations, and measurable scholarly impact. His research activities have contributed to scientific understanding within the field of virus-related medicine while supporting evidence-based clinical and translational research initiatives.[1]

Abstract

Giuseppe Stragliotto is recognized for sustained scientific contributions in virology and infectious disease research through clinical investigation, multidisciplinary collaboration, and scholarly publication. His documented research output demonstrates consistent engagement with virus-related studies, supporting advances in diagnosis, treatment strategies, and evidence-based medical practice. Citation metrics, publication productivity, and international visibility indicate measurable academic influence within the scientific community. These achievements provide a strong foundation for consideration for the Innovative Research Award, reflecting professional excellence, continued research commitment, and meaningful contributions to advancing infectious disease knowledge and improving future healthcare research initiatives worldwide.[1]

Keywords

Virus, Virology, Infectious Diseases, Clinical Research, Translational Medicine, Medical Science, Scholarly Publications, Research Impact, Academic Excellence, Innovation.

Introduction

Innovation in infectious disease research supports improved understanding of viral mechanisms, patient management, and future healthcare solutions. Academic recognition highlights researchers whose published work demonstrates scientific quality, collaborative engagement, and measurable influence across international research communities through peer-reviewed evidence and responsible scientific practice.[2]

Research Profile

Giuseppe Stragliotto is affiliated with Karolinska University Hospital, Stockholm, Sweden. His Scopus profile records thirty-one indexed publications with more than three thousand citations and an h-index of eighteen, reflecting sustained scholarly productivity and recognized influence within virus-related biomedical research.[1]

Research Contributions

Research contributions emphasize virology, infectious diseases, interdisciplinary collaboration, and clinically relevant investigations. Published studies have supported scientific understanding through evidence-based methodologies, encouraging knowledge dissemination while strengthening the connection between laboratory discoveries and practical healthcare applications across international scientific networks.[3]

Publications

The documented publication portfolio demonstrates continuous participation in peer-reviewed scientific literature. Indexed articles contribute to the visibility of virus research and provide accessible evidence for clinicians, researchers, and academic institutions seeking reliable scientific findings within infectious disease investigations.[1]

Research Impact

Citation performance and bibliometric indicators demonstrate broad scholarly recognition. More than three thousand citations and an h-index of eighteen indicate that published research has influenced subsequent scientific investigations, supporting continued advancement of virology and infectious disease research through widely referenced academic contributions.[1]

Award Suitability

The documented academic profile demonstrates characteristics commonly associated with research excellence, including peer-reviewed productivity, measurable citation impact, international collaboration, and continued engagement in virus research. These factors support consideration for the Innovative Research Award using transparent scholarly evaluation criteria.[2]

Conclusion

Giuseppe Stragliotto’s documented scholarly achievements illustrate consistent scientific engagement and measurable academic influence. His publication record, citation performance, and contributions to virus research represent a professional research profile appropriate for recognition within international academic award programs dedicated to infectious disease research.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Giuseppe Stragliotto, Author ID 6602379408. Scopus.
    https://www.scopus.com/pages/authors/6602379408
  2. ORCID. (n.d.). Researcher Profile: Giuseppe Stragliotto.
    https://orcid.org/0000-0003-1968-6447
  3. Pantalone, M. R., Stragliotto, G., Martin-Almazan, N., Peredo-Harvey, I., Jimenez-Macias, J. L., Rahbar, A., Lawler, S., Bartek, J., & Söderberg-Naucler, C. (n.d.). Valganciclovir therapy prevents human cytomegalovirus reactivation in glioblastoma patients undergoing radiochemotherapy and extends time to tumor progression.
    https://www.mdpi.com/2072-6694/18/10/1575

Refiloe Malesa | E coli | Innovative Research Award

Posted on by International Research Awards on Infectious Diseases

Innovative Research Award

Refiloe Malesa
Affiliation Agricultural Research Council
Country South Africa
Scopus ID 57215971261
Documents 6
Citations 30
h-index 3
Subject Area E coli
Event International Research Awards on Infectious Diseases
ORCID 0000-0002-5205-695X

Refiloe Malesa
Agricultural Research Council, South Africa

Refiloe Malesa is associated with the Agricultural Research Council in South Africa and has contributed to research involving Escherichia coli, food safety, microbial surveillance, and infectious disease monitoring. The available scholarly metrics indicate six indexed publications, thirty citations, and an h-index of three, reflecting a developing research profile with contributions relevant to public health, agricultural microbiology, and pathogen surveillance.[1]

Abstract

Refiloe Malesa has contributed to research concerning Escherichia coli, food safety, agricultural microbiology, and infectious disease surveillance. Published studies emphasize microbial detection, epidemiological monitoring, and laboratory investigations supporting public health decision-making. These contributions improve understanding of pathogen occurrence, antimicrobial concerns, and preventive strategies within agricultural and environmental systems. Although the publication portfolio is developing, the research demonstrates scientific rigor and practical relevance for infectious disease management. The documented scholarly output, supported by citations and recognized indexing, illustrates meaningful participation in microbiological research while promoting evidence-based approaches that strengthen disease surveillance, food security, and One Health initiatives worldwide.[1][2]

Keywords

Escherichia coli, Food Safety, Agricultural Microbiology, Infectious Diseases, Public Health, Epidemiology, Pathogen Surveillance, Antimicrobial Resistance, One Health, Disease Monitoring.

Introduction

Research involving infectious microorganisms plays an essential role in protecting human and animal health. Investigations focused on Escherichia coli contribute to improved surveillance, risk assessment, and disease prevention. Such studies provide scientific evidence supporting food safety policies, agricultural practices, and microbiological monitoring across different environmental settings.[2]

Research Profile

Refiloe Malesa has established a developing academic profile through peer-reviewed publications indexed in Scopus. Current bibliometric indicators include six publications, thirty citations, and an h-index of three. Research activities primarily focus on microbiology, pathogen detection, and infectious disease-related investigations within agricultural and public health contexts.[1]

Research Contributions

The research contributions emphasize laboratory-based investigations of bacterial pathogens, especially Escherichia coli. The studies support microbial surveillance, food quality assessment, epidemiological understanding, and evidence-based interventions that enhance disease prevention while strengthening collaboration between agricultural and public health research disciplines.[2]

Publications

The documented publication record consists of six indexed research articles covering microbiology, pathogen surveillance, and infectious disease-related topics. These publications collectively demonstrate scientific engagement and contribute valuable evidence supporting microbial monitoring, laboratory diagnostics, and disease control strategies relevant to agricultural and public health systems.[1]

Research Impact

Bibliometric indicators, including thirty citations and an h-index of three, suggest that the published research has achieved measurable academic recognition. Continued investigations and collaborative studies have the potential to expand scientific influence while supporting advancements in infectious disease surveillance, food safety, and microbial risk management.[3]

Award Suitability

The Innovative Research Award recognizes researchers demonstrating meaningful scientific contributions and emerging research excellence. Based on the available publication record and scholarly metrics, Refiloe Malesa’s work aligns with the objectives of the International Research Awards on Infectious Diseases by supporting microbiological research, disease surveillance, and evidence-based public health initiatives.[1]

Conclusion

The available scholarly record reflects consistent engagement in infectious disease-related microbiological research. Through investigations involving Escherichia coli, Refiloe Malesa contributes to scientific understanding that supports disease prevention, food safety, and public health. Continued research activity is expected to further strengthen academic impact and interdisciplinary collaboration.[1]

References

  1. Elsevier. (n.d.). Scopus Author Details: Refiloe Malesa, Author ID 57215971261. Scopus.
    https://www.scopus.com/pages/authors/57215971261
  2. Malesa, R. P., Pierneef, R. E., Magwedere, K., Mafuna, T., & Matle, I. (n.d.). Shifting genomes, rising threats: Adaptive evolution and antimicrobial resistance of E. coli ST10 across African ecologies.
    https://www.sciencedirect.com/science/article/pii/S0888754326000868
  3. ORCID. (n.d.). ORCID Record: Refiloe Malesa.
    https://orcid.org/0000-0002-5205-695X